Clinical Trial

Muscle-Specific Multimodal AI for Sarcopenia Diagnosis

Study acronym: SARC-AI
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to develop a muscle-specific multimodal artificial intelligence (AI) model for the diagnosis of sarcopenia and to investigate the effects of rehabilitation training on muscle aging. Clinical, functional, and imaging data will be collected from participants with muscle function decline. Multimodal data, including muscle function measurements and clinical assessments, will be integrated to develop and validate an AI-based diagnostic model for sarcopenia. In addition, the effects of rehabilitation training on muscle function and muscle aging-related outcomes will be evaluated. The results of this study are expected to contribute to the development of digital biomarkers and precision rehabilitation strategies for sarcopenia.
Trial Details
NCT Number NCT07477574
Lead Sponsor Seoul National University Bundang Hospital
Conditions Sarcopenia
Enrollment 75 participants
Start Date 2026-03-01
Primary Completion 2028-02-28 (estimated)
Study Completion 2028-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-03-17